Description
(Text)
This book explores the intricate landscape of prion diseases, exploring the various methodologies for detecting human and animal prions, emphasizing both current techniques and those under development, as well as emerging techniques and methodologies for biomarker detection in prion diseases, paving the way for improved diagnostic and therapeutic approaches.
The rational development of theranostic small molecules for prion diseases is also included, shedding light on potential treatment. It examines the utility of prion disease diagnostic markers in pre-symptomatic disease stages, offering insights into early detection strategies.
Pharmacological approaches in prion diseases are explored, along with the potential of Lab-on-Chip platforms for monitoring prion and "prion-like" amyloid assembly and behavior. The role of reactive microglia and astrocytes as therapeutic targets is investigated, highlighting novel avenues for intervention.
Furthermore, the bookaddresses biological fluid biomarkers in human prion diseases, paying special attention to biosafety considerations. Human genetic evidence is analyzed to identify new targets in prion diseases, discussing both opportunities and challenges.
The utilization of RT-QuIC analysis of peripheral tissues and PMCA applications in prion disease diagnosis is examined, along with the extension of seed amplification assays for the clinical diagnosis of neurodegenerative disorders beyond prion pathologies. Overall, the book provides a comprehensive overview of biomarkers and therapeutic targets in prion diseases, encapsulating both current knowledge and emerging trends in the field.
Chapter 10 is available open access under a Creative Commons Attribution 4.0 International License via link.springer.com.
(Table of content)
Chapter 1. Advancements in Chronic Wasting Disease (CWD) Prion Detection: Moving Beyond The Gold Standards.- Chapter 2. Diagnosis of Prion Diseases.- Chapter 3. New Therapeutic Modalities in Prion Diseases.- Chapter 4. Prion Disease Diagnostic Biomarker Utility In Pre-Symptomatic Disease.- Chapter 5. Therapeutic Trajectories in Human Prion Diseases.- Chapter 6. Prion and Prion-Like Detection: From Conventional Methods To Microfluidics Or Lab-On-Chip Platforms To Monitor Seeding And Spreading Of Misfolded Proteins.- Chapter 7. Tracking Prions by RT-QuIC: an Update.- Chapter 8. Reactive Microglia And Astrocytes As Therapeutic Targets In Prion Diseases.- Chapter 9. Biological Fluid Biomarkers in Human Prion Diseases with a Note on Biosafety.- Chapter 10. Human Genetic Evidence for New Targets in Prion Diseases Opportunities and Challenges.- Chapter 11. Advancing Prion Diagnostics: RT-QuIC Applications In Peripheral Tissues.- Chapter 12. Detecting the Undetectable: Exploring The Diagnostic Potential Of Protein Misfolding Cyclic Amplification In Human Prion Diseases.- Chapter 13. Seed Amplification Assays As Powerful Tools For Detecting Peripheral Biomarkers In Prion-Like Diseases.
